Bronchoscopic Evaluation of Severe Asthma
- 1 September 1997
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 156 (3) , 737-743
- https://doi.org/10.1164/ajrccm.156.3.9610046
Abstract
The role of inflammation in the pathogenesis of severe asthma chronically treated with high doses of glucocorticoids is poorly understood. Despite this, treatment has been aimed at advancing anti- inflammatory and immunomodulator therapy. This study was designed to evaluate both the presence and type of airway inflammation in patients with severe asthma. A prospective bronchoscopic study evaluated 14 severe, high-dose oral glucocorticoid dependent asthmatics. Bronchoalveolar lavage fluid was analyzed for cytology and inflammatory mediators. Endobronchial and transbronchial biopsies were performed in selected patients for morphometric evaluation of macrophage/monocytes, neutrophils, eosinophils and lymphocytes. These results were compared with lavage and endo- and transbronchial biopsy studies in normal controls and patients with moderate asthma. The concentration of eosinophils in bronchoalveolar lavage fluid was highest in the moderate asthmatics not on glucocorticoids, with very little difference between normal controls and severe asthmatics (significant difference among the groups, p = 0.007). In contrast, the severe asthmatics demonstrated a twofold higher concentration of neutrophils in lavage than either the mild-moderate asthmatics, or the normal controls (p = 0.032 among the groups, p < 0.05 between the severe asthmatics and both controls). Similar results were obtained in the endobronchial and transbronchial biopsy specimens, which consistently showed significantly higher numbers of neutrophils in the severe asthmatics than in the control groups. The eicosanoid mediators, thromboxane and leukotriene B4, were also highest in the severe asthma group (differences among the groups, p = 0.019 and p = 0.023, respectively). These findings suggest that inflammation remains in severe symptomatic asthmatics despite treatment with high dose glucocorticoids which may be due to the severity of disease, glucocorticoid treatment, or other as yet undefined factors.Keywords
This publication has 19 references indexed in Scilit:
- Effect of 5-lipoxygenase inhibition on bronchoconstriction and airway inflammation in nocturnal asthma.American Journal of Respiratory and Critical Care Medicine, 1995
- Effect of high dose inhaled fluticasone propionate on airway inflammation in asthma.American Journal of Respiratory and Critical Care Medicine, 1995
- Effect of inhaled beclomethasone dipropionate on expression of proinflammatory cytokines and activated eosinophils in the bronchial epithelium of patients with mild asthmaJournal of Allergy and Clinical Immunology, 1994
- Effect of glucocorticoids on collagen accumulation in pulmonary vascular remodeling in the rat.American Journal of Respiratory and Critical Care Medicine, 1994
- Sudden-Onset Fatal Asthma: A Distinct Entity with Few Eosinophils and Relatively More Neutrophils in the Airway Submucosa?American Review of Respiratory Disease, 1993
- Airway Mucosal Inflammation Even in Patients with Newly Diagnosed AsthmaAmerican Review of Respiratory Disease, 1993
- Dexamethasone-induced Increase in Platelet-derived Growth Factor (B) mRNA in Human Alveolar Macrophages and Myelomonocytic HL60 Macrophage-like CellsAmerican Journal of Respiratory Cell and Molecular Biology, 1992
- An Economic Evaluation of Asthma in the United StatesNew England Journal of Medicine, 1992
- Effect of an Inhaled Corticosteroid on Airway Inflammation and Symptoms in AsthmaAmerican Review of Respiratory Disease, 1992
- Stereology of arbitrary particles*Journal of Microscopy, 1986